CONDYDAV: A multicentre observational study of patients presenting external genital warts in France

• Published in: Annales de dermatologie et de vénéréologie Vol. 143; no. 11; pp. 675 - 681
• Main Authors: Chanal, J, Fouéré, S, Yassir-Oria, F, Spenatto, N, Bouscarat, F, Picot, E, Martinet, P, Vernay-Vaisse, C, Pelletier, F, Courtieu, C, Baclet, V, Bernier, C, Aymar-Moulene, D, Dupuis-Fourdan, F, Passeron, A, Bara-Passot, C, Pinault, A-L, Misery, L, Janier, M, Dupin, N
• Format: Journal Article
• Language: French
• Published: France 01.11.2016
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Anus Diseases - epidemiology; Anus Diseases - therapy; Condylomata Acuminata - epidemiology; Condylomata Acuminata - therapy; Cryotherapy; Female; France - epidemiology; Genital Diseases, Female - epidemiology; Genital Diseases, Female - therapy; Genital Diseases, Male - epidemiology; Genital Diseases, Male - therapy; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Male; Middle Aged; Prospective Studies; Sexual Partners; Sexuality - statistics & numerical data; Young Adult; Anogenital warts; Condylomes; Dispensaires antivénériens; Épidémiologie; Condyloma acuminata; France; Epidemiology
• ISSN: 0151-9638
• DOI: 10.1016/j.annder.2016.05.013

Since 2007 in France, human papilloma virus (HPV) vaccination has been licensed for use as a vaccine against HPV 6, 11, 16 and 18. The impact on the epidemiology of external genital warts (EGWs) in a large population remains unclear. To determine epidemiologic and clinical features of patients presenting EGWs in France in the era of HPV vaccination. In this prospective, observational study, we analyzed clinical features and treatments between January 1st, 2012 and March 31, 2012 for patients consulting for EGWs at 15 STI clinics throughout France. A total of 372 men and 111 women were included; mean age 31.2 years. The women were younger than the men (31.7 and 28.9 years respectively P<0.05). Among the patients, 416 (85.7%) were heterosexual, 13 bisexual and 54 (11.2%) homosexual, including one female. Males reported more sexual partners in the last 12 months (more than 3 partners in 32.6% versus 11.9%, P<0.01). Among the men, 230 had involvement of the penis alone and 46 had involvement of the anus alone. Seventy-six patients had EGWs of the anus, and of these 26 were MSM. In females, 76 had an infection of the vulva alone and 22 co-infection of the vulva and anus. MSM and females were at higher risk than heterosexual males for anal involvement (P<0.0001 and P=0.004, respectively). Three women had been vaccinated: two with Gardasil and one with Cervarix . Cryotherapy was the preferred treatment. With the advent of HPV vaccination, a global strategy for the prevention and treatment of EGW should be implemented.